Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Artificial intelligence in cell culture media and process development

    Forecasted

    Artificial intelligence in cell culture media and process development supports researchers building adaptable models to optimize media feeds across mammalian hosts, improving bioprocess efficiency and conserving resources.

    Browse similar grants
    AI Research Grants 2026AI in Healthcare Research Grants
    OverviewSimilar Grants
    OverviewSimilar Grants

    In-vitro models & assays to identify novel therapies for neuroinflammatory diseases

    In-vitro models & assays to identify novel therapies for neuroinflammatory diseases supports researchers developing human-centered models and assays to discover and optimize small-molecule treatments.

    EMD Group (Merck KGaA)Forecasted Aug 31, 2027$500,000Forecasted

    Advancing Research at the intersection of Biology and Artificial Intelligence/Machine Learning (AI/ML)

    NSF BIO supports research combining biology and AI/ML to advance biological discovery or develop AI/ML methods inspired by biological systems, encouraging interdisciplinary collaboration.

    NSFRolling submissions

    AI-human collaborations in cancer

    This grant funds global teams to develop advanced AI agents that work with human researchers to generate and test new cancer research hypotheses, transforming how cancer is studied.

    CGCForecasted Oct 23, 2026· 5d$20,000,000Forecasted

    Artificial Intelligence in Communication Sciences and Disorders Research Grant

    Supports interdisciplinary research integrating ethical and innovative AI solutions to advance clinical practice, education, and research in communication sciences and disorders.

    ASHAForecasted Mar 4, 2027$50,000Forecasted

    Condensate-Based High-Sensitivity Cell-Free Screening Assays for the modulation of PPIs

    Condensate-Based High-Sensitivity Cell-Free Screening Assays for the modulation of PPIs supports researchers developing cell-free assays to detect weak protein interactions and aid drug discovery.

    EMD Group (Merck KGaA)Forecasted Aug 31, 2027$300,000Forecasted